MyAverix Finance MyAverix Finance

STU

Shanghai Pharmaceuticals Holding Co Ltd (S1R)

Shanghai Pharmaceuticals Holding Co Ltd (S1R) is listed on STU. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for S1R

P/E ratio
18.00

Shanghai Pharmaceuticals Holding Co Ltd (S1R) — FAQ

What is S1R's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Pharmaceuticals Holding Co Ltd (S1R) is 18.00 (data as of 2026-05-24).

Does Shanghai Pharmaceuticals Holding Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Pharmaceuticals Holding Co Ltd (S1R). Check the MyAverix Finance app for the latest dividend data.

What exchange is S1R listed on?

S1R is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play